(Q34163923)

31 July 2017

title

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia (English)

1 reference

31 July 2017

0 references

Dean B

1

1 reference

31 July 2017

McLeod M

2

1 reference

31 July 2017

Keriakous D

3

1 reference

31 July 2017

McKenzie J

4

1 reference

31 July 2017

Scarr E

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

31 July 2017

number of pages

9

1 reference

inferred from page(s)

published in

Molecular Psychiatry

1 reference

31 July 2017

volume

7

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

1083-1091

1 reference

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Radioreceptor binding profile of the atypical antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Olanzapine: a novel atypical neuroleptic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Therapeutic opportunities from muscarinic receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Muscarinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Role of the M1 receptor in regulating circadian rhythms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Elucidating the role of muscarinic receptors in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

Treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

7 January 2021

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001199

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001199

1 reference

31 July 2017

1 reference